VRTXon logo

Vertex Pharmaceuticals Inc (VRTX)

Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain. It mar...

NASDAQHealthcareBiotechnologyUSA

Company Profile

Stock Code
VRTX
ISIN Code
US92532F1003
Currency
US Dollar (USD)
IPO Date
1991-07-24

Contact Information

Company Address
50 Northern Avenue, Boston, MA, United States, 02210
Contact Phone
617 341 6100
Company Website
https://www.vrtx.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$999,999.99
Return on Assets (TTM)
12.14%
EBITDA
$999,999.99
Revenue (TTM)
$999,999.99